As of Aug 28
| +0.08 / +3.52%|
The 1 analysts offering 12-month price forecasts for Amarantus Bioscience Holdings Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 18.00. The median estimate represents a +665.96% increase from the last price of 2.35.
The current consensus among 1 polled investment analysts is to Buy stock in Amarantus Bioscience Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.